Literature DB >> 8915155

Fatal cardiomyopathy in dystrophic epidermolysis bullosa.

C Melville1, D Atherton, M Burch, A Cohn, I Sullivan.   

Abstract

Two unrelated children with autosomal recessive dystrophic epidermolysis bullosa (RDEB) developed fatal dilated cardiomyopathy. Both were malnourished and had severe growth problems. We believe that the most likely cause for the cardiomyopathy is a micronutrient deficiency, most probably selenium deficiency, since the serum selenium level was found to be reduced in the case in whom we measured this, and in 14 of 25 other children with dystrophic epidermolysis bullosa. Echocardiographic screening of 18 other patients revealed no evidence of cardiomyopathy. We recommend careful attention to nutrition, with prospective monitoring of vitamins and micronutrients including selenium and carnitine, and regular echocardiographic screening of patients with severe RDEB.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8915155

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  4 in total

1.  ADHD: A new practice guideline from the American Academy of Pediatrics. Attention deficit hyperactive disorder.

Authors:  H Bauchner
Journal:  Arch Dis Child       Date:  2000-07       Impact factor: 3.791

Review 2.  Dilated cardiomyopathy in dystrophic epidermolysis bullosa.

Authors:  R U Sidwell; R Yates; D Atherton
Journal:  Arch Dis Child       Date:  2000-07       Impact factor: 3.791

3.  The analysis of echocardiographic results in patients suffering from epidermolysis bullosa.

Authors:  Katarzyna Kurnicka; Katarzyna Osipowicz; Olga Dzikowska-Diduch; Katarzyna Wertheim-Tysarowska; Cezary Kowalewski; Piotr Pruszczyk
Journal:  Postepy Dermatol Alergol       Date:  2021-01-06       Impact factor: 1.837

4.  The risk of cardiomyopathy in inherited epidermolysis bullosa.

Authors:  J-D Fine; M Hall; M Weiner; K-P Li; C Suchindran
Journal:  Br J Dermatol       Date:  2008-07-04       Impact factor: 9.302

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.